Online citations, reference lists, and bibliographies.

Hsa-miR-134 Suppresses Non-small Cell Lung Cancer (NSCLC) Development Through Down-regulation Of CCND1

Cheng-Cao Sun, Shu-jun Li, Dejia Li
Published 2016 · Medicine, Biology
Cite This
Download PDF
Analyze on Scholarcy
Share
Hsa-miRNA-134 (miR-134) has recently been discovered to have anticancer efficacy in different organs. However, the role of miR-134 on non-small cell lung cancer (NSCLC) is still ambiguous. In this study, we investigated the role of miR-134 on the development of NSCLC. The results indicated that miR-134 was significantly down-regulated in primary tumor tissues and very low levels were found in NSCLC cell lines. Ectopic expression of miR-134 in NSCLC cell lines significantly suppressed cell growth as evidenced by cell viability assay, colony formation assay and BrdU staining, through inhibition of cyclin D1, cyclin D2, CDK4 and up-regulation of p57(Kip2) and p21(Waf1/Cip1). In addition, miR-134 induced apoptosis, as indicated by concomitantly with up-regulation of key apoptosis protein cleaved caspase-3, and down-regulation of anti-apoptosis protein Bcl2. Moreover, miR-134 inhibited cellular migration and invasiveness through inhibition of matrix metalloproteinases (MMP)-7 and MMP-9. Further, oncogene CCND1 was revealed to be a putative target of miR-134, which was inversely correlated with miR-134 expression in NSCLC. Taken together, our results demonstrated that miR-134 played a pivotal role on NSCLC through inhibiting cell proliferation, migration, invasion, and promoting apoptosis by targeting oncogenic CCND1.
This paper references
10.1016/j.febslet.2012.09.016
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Jipeng Li (2012)
10.1016/j.molcel.2014.07.017
A MicroRNA precursor surveillance system in quality control of MicroRNA synthesis.
X Sherry Liu (2014)
10.1152/japplphysiol.00721.2015
Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling.
Chengcao Sun (2016)
10.1038/nm.3862
The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes
Bengt-Frederik Belgardt (2015)
10.1038/cdd.2015.95
miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation
Zhongfei Li (2017)
10.1165/rcmb.2013-0195OC
MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis.
Sudipta Das (2014)
10.1091/mbc.6.4.387
Inhibition of cyclin-dependent kinases by p21.
J. W. Harper (1995)
miR-134 induces oncogenicity and metastasis Oncotarget 35977 www.impactjournals.com/oncotarget in head and neck carcinoma through targeting WWOX gene
CJ Liu (2014)
10.1038/nrc2465
The TRAIL apoptotic pathway in cancer onset, progression and therapy
R. Johnstone (2008)
10.1186/1476-4598-13-212
MicroRNA-21 inhibits p57Kip2 expression in prostate cancer
Sweta Mishra (2014)
10.1016/j.cell.2012.02.005
MicroRNAs in Stress Signaling and Human Disease
Joshua T Mendell (2012)
Cyclin D 1 in non - small cell
O Gautschi
Downregulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells
T Shuang (2015)
10.1016/j.stem.2010.06.012
MicroRNAs as regulators of differentiation and cell fate decisions.
K. Ivey (2010)
10.1007/s10529-015-1941-y
MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
Lin Lu (2015)
10.1089/dna.2014.2629
miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Yiyang Liu (2015)
10.1186/1476-4598-13-124
microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer
L. Zhang (2013)
10.18632/oncotarget.5285
High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR-134 on CD86 in a murine melanoma model
Shi-mei Yuan (2015)
10.1002/path.4289
A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition.
Juan C. Díaz-Martín (2014)
10.1056/nejmoa011954
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
J. Schiller (2002)
10.1038/nrc2628
Tumour necrosis factor and cancer
F. Balkwill (2009)
10.18632/oncotarget.5476
Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
Chengcao Sun (2015)
10.1038/onc.2010.253
The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2
X. Zeng (2010)
10.1038/384470a0
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
P. Sicinski (1996)
Hepatocyte nuclear factor-4alpha reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region. Hepatology
C Yin (2013)
10.1016/j.lungcan.2006.09.024
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
O. Gautschi (2007)
10.1152/japplphysiol.00744.2014
Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2.
Chengcao Sun (2015)
10.1007/s11626-012-9482-3
MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation
Xiaoying Zhang (2012)
signals centrosome amplification in mammary epithelial cells through cyclin D 1 / Cdk 4 and Nek 2
P Sicinski (2010)
10.1038/ncomms8652
NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
S. Yan (2015)
Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta1 in hepatocellular carcinoma
R Zha (2014)
10.1038/nature03816
Stem cell division is regulated by the microRNA pathway
S. Hatfield (2005)
10.1038/cdd.2015.78
Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling
X. Tang (2016)
10.1038/srep11909
miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis
Ke Chen (2015)
10.3892/ijo.2013.1844
MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression
Chao-Shi Niu (2013)
10.1016/j.febslet.2014.12.002
MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.
Yongtao Gao (2015)
10.1016/j.canlet.2011.10.015
Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD).
Yuan Fu Qiu (2012)
10.1016/j.molcel.2014.03.049
Unambiguous identification of miRNA:target site interactions by different types of ligation reactions.
Stefanie Grosswendt (2014)
10.1158/1078-0432.CCR-08-3185
Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas
A. Italiano (2009)
Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related www.impactjournals.com/oncotarget Factor 2 (Nrf2)-mediated Inhibition of NF-kappaB Signaling Pathway
C C Sun (2015)
10.18632/ONCOTARGET.2577
MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer
Yue Zhang (2014)
10.1006/excr.1998.4319
Transcriptional regulation of the p21((WAF1/CIP1)) gene.
A. Gartel (1999)
10.1016/j.ejphar.2009.06.066
TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.
P. Holoch (2009)
10.1016/0092-8674(93)90500-P
WAF1, a potential mediator of p53 tumor suppression
W. El-Deiry (1993)
10.1002/path.4525
Methylation-induced loss of miR-484 in microsatellite-unstable colorectal cancer promotes both viability and IL-8 production via CD137L.
Q. Mei (2015)
10.1038/nature03702
MicroRNA expression profiles classify human cancers
J. Lu (2005)
10.1023/A:1025867130437
Role of matrix metalloproteinases (MMPs) in colorectal cancer
S. Zucker (2004)
10.18632/ONCOTARGET.2662
Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A
Hongxia Chen (2014)
SMYD 3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D 2 through H 4 K 20 me 3
F. Vieira (2015)
Hsa-miR-326 targets CCND1 and inhibits nonsmall cell lung cancer
C Sun (2016)
10.1002/path.4295
miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis.
Chia-Yi Hsu (2014)
10.15252/embj.201487921
MiR-134-dependent regulation of Pumilio-2 is necessary for homeostatic synaptic depression.
Roberto Fiore (2014)
10.1038/35082500
Specific protection against breast cancers by cyclin D1 ablation
Q. Yu (2001)
10.18632/oncotarget.7517
Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer
Cheng-Cao Sun (2016)
10.18632/oncotarget.5192
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
Keith. O'Brien (2015)
10.18632/ONCOTARGET.3767
SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
Filipa Quintela Vieira (2015)
10.1038/nrc3090
Cyclin D as a therapeutic target in cancer
E. Musgrove (2011)
10.1016/j.bbrc.2016.01.175
MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
Chengcao Sun (2016)
10.18632/oncotarget.7071
Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
Chengcao Sun (2016)
10.1016/j.bbrc.2015.07.021
MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway.
Tianjun Chen (2015)
10.1101/gad.815400
Matrix metalloproteinases: effectors of development and normal physiology.
T. Vu (2000)
10.1038/369669a0
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
T. Wang (1994)
10.1002/hep.26573
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
Chuan Yin (2013)
10.18632/oncotarget.4575
Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation
Chengcao Sun (2015)
10.5555/uri:pii:0093775488900449
Molecular genetics of lung cancer.
Y. Sekido (1988)
10.1016/j.yexcr.2014.10.022
The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Yan Chen (2015)
Hepatocyte nuclear factor - 4 alpha reverses malignancy of hepatocellular carcinoma through regulating miR - 134 in the DLK 1 - DIO 3 region
C Yin (2013)
High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR134 on CD86 in a murine melanoma model. Oncotarget
SM Yuan (2015)
miR-134 induces oncogenicity and metastasis www.impactjournals.com/oncotarget in head and neck carcinoma through targeting WWOX gene
C J Liu (2014)
10.1016/0092-8674(93)90499-G
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
J. Harper (1993)



This paper is referenced by
10.1002/jcb.29586
miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
H. Huang (2020)
10.7150/ijms.28047
Circular RNA: a novel biomarker and therapeutic target for human cancers
Bo Lei (2019)
10.1016/j.gene.2018.09.032
Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p/KLF12 axis.
Peng Song (2019)
10.1038/onc.2017.151
A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood
Ana Rita Lourenço (2017)
10.1016/j.gene.2018.08.064
MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1.
Shao-bo Ke (2018)
10.1111/cpr.12548
Circ_0078767 suppresses non‐small‐cell lung cancer by protecting RASSF1A expression via sponging miR‐330‐3p
T. Chen (2019)
10.1080/15592294.2017.1356555
Disease relevant modifications of the methylome and transcriptome by particulate matter (PM2.5) from biomass combustion
Katharina Heßelbach (2017)
10.1016/j.gene.2019.02.019
Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis.
Dan He (2019)
10.1016/j.biopha.2018.07.164
Advances of circular RNAs in carcinoma.
Xiao-Yue Xu (2018)
miR-3175 and miR-134 affect proliferation, invasion and apoptosis of glioma cells through PI3K/AKT signaling pathway.
Aiqin Qi (2019)
10.1016/j.gene.2016.08.002
Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression.
Xiaojun Yang (2016)
10.21037/ncri.2018.04.04
Could miR-134 be a marker of ionizing radiation toxicity?
E. Jiménez-Mateos (2018)
10.1080/17476348.2017.1355241
DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer
Jhon R. Enterina (2017)
10.1016/j.bbrc.2016.08.030
Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Jing Fang (2016)
10.1002/1878-0261.12112
Identification of driver copy number alterations in diverse cancer types and application in drug repositioning
Wenbin Zhou (2017)
microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).
Y. Li (2018)
10.1016/j.gene.2017.11.066
The miR-875-5p inhibits SATB2 to promote the invasion of lung cancer cells.
J. Wang (2018)
10.1016/j.biopha.2016.12.007
miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer.
Tianjun Chen (2017)
10.1111/1440-1681.12780
Highly expressed long non‐coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non‐small cell lung carcinoma
X Liu (2017)
10.1002/jcb.28089
A novel messenger RNA and long noncoding RNA signature associated with the progression of nonmuscle invasive bladder cancer.
Yu-hui He (2018)
10.1016/j.gene.2017.01.009
Long non-coding RNA FTH1P3 facilitates oral squamous cell carcinoma progression by acting as a molecular sponge of miR-224-5p to modulate fizzled 5 expression.
C. Zhang (2017)
10.1016/j.yexcr.2017.11.027
MicroRNA‐30e‐5p suppresses non‐small cell lung cancer tumorigenesis by regulating USP22‐mediated Sirt1/JAK/STAT3 signaling
Gaojun Xu (2018)
10.1016/j.gene.2017.12.051
Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma.
Xiabin Lan (2018)
10.2147/OTT.S143465
miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells
Kankan Chen (2018)
10.1371/journal.pgen.1007837
regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors
Gary Wilk (2018)
10.1038/mtna.2016.94
Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non–small-cell Lung Cancer by Binding to EZH2 and Suppressing p57
C. Sun (2016)
10.1093/carcin/bgx063
Matrix metalloproteinases: their functional role in lung cancer.
N. Merchant (2017)
10.18632/oncotarget.12005
Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies
Xinrui Shi (2016)
10.1139/bcb-2018-0211
MicroRNA-134 Deactivates Hepatic Stellate Cells by Targeting TGF-β Activated Kinase 1-Binding Protein 1.
P. Wang (2019)
10.1371/journal.pone.0184746
Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p
X. Zheng (2017)
10.1016/j.bbrc.2017.05.155
Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma.
C. Zhang (2017)
The essential role of DICER in spermatogenesis and male fertility
Hanna Korhonen (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar